Aim: To establish a ‘response framework’ that alleviates administrative, regulatory and ethical bottlenecks and ensures ALERRT can act swiftly to initiate research.

 

.............................................................................................................................................. April 2020

ALERRT COVID-19 Clinical Characterisation Protocol

The Wellcome Trust and the UK Department for International Development (DFID) have awarded a substantial grant to Dr John Amuasi from the Kumasi Center for Collaborative Research in Tropical Medicine to fund the ALERRT COVID-19 Clinical Characterisation Protocol (CCP).

ISARIC, the International Severe Acute Respiratory and emerging Infection Consortium has developed a clinical characterisation protocol for COVID-19. This protocol has been endorsed by the WHO and is currently being used in China and across Europe.

ALERRT will work closely with the WHO/AFRO, Africa CDC and existing networks and structures across Africa and globally to adapt the CCP for implementation in Africa.